Diagnosis, monitoring, and treatment of primary ciliary dyskinesia

PCD foundation consensus recommendations based on state of the art review

Adam J. Shapiro, Maimoona A. Zariwala, Thomas Ferkol, Stephanie Davis, Scott D. Sagel, Sharon D. Dell, Margaret Rosenfeld, Kenneth N. Olivier, Carlos Milla, Sam J. Daniel, Adam J. Kimple, Michele Manion, Michael R. Knowles, Margaret W. Leigh

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Summary Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, rare lung disease resulting in chronic oto-sino-pulmonary disease in both children and adults. Many physicians incorrectly diagnose PCD or eliminate PCD from their differential diagnosis due to inexperience with diagnostic testing methods. Thus far, all therapies used for PCD are unproven through large clinical trials. This review article outlines consensus recommendations from PCD physicians in North America who have been engaged in a PCD centered research consortium for the last 10 years. These recommendations have been adopted by the governing board of the PCD Foundation to provide guidance for PCD clinical centers for diagnostic testing, monitoring, and appropriate short and long-term therapeutics in PCD patients.

Original languageEnglish (US)
Pages (from-to)115-132
Number of pages18
JournalPediatric Pulmonology
Volume51
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Kartagener Syndrome
Therapeutics
Lung Diseases
Governing Board
Physicians
Rare Diseases
North America
Differential Diagnosis
Clinical Trials

Keywords

  • consensus statement
  • PCD Foundation
  • PCD, kartagener
  • primary ciliary dyskinesia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Diagnosis, monitoring, and treatment of primary ciliary dyskinesia : PCD foundation consensus recommendations based on state of the art review. / Shapiro, Adam J.; Zariwala, Maimoona A.; Ferkol, Thomas; Davis, Stephanie; Sagel, Scott D.; Dell, Sharon D.; Rosenfeld, Margaret; Olivier, Kenneth N.; Milla, Carlos; Daniel, Sam J.; Kimple, Adam J.; Manion, Michele; Knowles, Michael R.; Leigh, Margaret W.

In: Pediatric Pulmonology, Vol. 51, No. 2, 01.02.2016, p. 115-132.

Research output: Contribution to journalArticle

Shapiro, AJ, Zariwala, MA, Ferkol, T, Davis, S, Sagel, SD, Dell, SD, Rosenfeld, M, Olivier, KN, Milla, C, Daniel, SJ, Kimple, AJ, Manion, M, Knowles, MR & Leigh, MW 2016, 'Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review', Pediatric Pulmonology, vol. 51, no. 2, pp. 115-132. https://doi.org/10.1002/ppul.23304
Shapiro, Adam J. ; Zariwala, Maimoona A. ; Ferkol, Thomas ; Davis, Stephanie ; Sagel, Scott D. ; Dell, Sharon D. ; Rosenfeld, Margaret ; Olivier, Kenneth N. ; Milla, Carlos ; Daniel, Sam J. ; Kimple, Adam J. ; Manion, Michele ; Knowles, Michael R. ; Leigh, Margaret W. / Diagnosis, monitoring, and treatment of primary ciliary dyskinesia : PCD foundation consensus recommendations based on state of the art review. In: Pediatric Pulmonology. 2016 ; Vol. 51, No. 2. pp. 115-132.
@article{5c33e84c74484c1c948caffc46384d80,
title = "Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review",
abstract = "Summary Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, rare lung disease resulting in chronic oto-sino-pulmonary disease in both children and adults. Many physicians incorrectly diagnose PCD or eliminate PCD from their differential diagnosis due to inexperience with diagnostic testing methods. Thus far, all therapies used for PCD are unproven through large clinical trials. This review article outlines consensus recommendations from PCD physicians in North America who have been engaged in a PCD centered research consortium for the last 10 years. These recommendations have been adopted by the governing board of the PCD Foundation to provide guidance for PCD clinical centers for diagnostic testing, monitoring, and appropriate short and long-term therapeutics in PCD patients.",
keywords = "consensus statement, PCD Foundation, PCD, kartagener, primary ciliary dyskinesia",
author = "Shapiro, {Adam J.} and Zariwala, {Maimoona A.} and Thomas Ferkol and Stephanie Davis and Sagel, {Scott D.} and Dell, {Sharon D.} and Margaret Rosenfeld and Olivier, {Kenneth N.} and Carlos Milla and Daniel, {Sam J.} and Kimple, {Adam J.} and Michele Manion and Knowles, {Michael R.} and Leigh, {Margaret W.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1002/ppul.23304",
language = "English (US)",
volume = "51",
pages = "115--132",
journal = "Pediatric Pulmonology",
issn = "8755-6863",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Diagnosis, monitoring, and treatment of primary ciliary dyskinesia

T2 - PCD foundation consensus recommendations based on state of the art review

AU - Shapiro, Adam J.

AU - Zariwala, Maimoona A.

AU - Ferkol, Thomas

AU - Davis, Stephanie

AU - Sagel, Scott D.

AU - Dell, Sharon D.

AU - Rosenfeld, Margaret

AU - Olivier, Kenneth N.

AU - Milla, Carlos

AU - Daniel, Sam J.

AU - Kimple, Adam J.

AU - Manion, Michele

AU - Knowles, Michael R.

AU - Leigh, Margaret W.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Summary Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, rare lung disease resulting in chronic oto-sino-pulmonary disease in both children and adults. Many physicians incorrectly diagnose PCD or eliminate PCD from their differential diagnosis due to inexperience with diagnostic testing methods. Thus far, all therapies used for PCD are unproven through large clinical trials. This review article outlines consensus recommendations from PCD physicians in North America who have been engaged in a PCD centered research consortium for the last 10 years. These recommendations have been adopted by the governing board of the PCD Foundation to provide guidance for PCD clinical centers for diagnostic testing, monitoring, and appropriate short and long-term therapeutics in PCD patients.

AB - Summary Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, rare lung disease resulting in chronic oto-sino-pulmonary disease in both children and adults. Many physicians incorrectly diagnose PCD or eliminate PCD from their differential diagnosis due to inexperience with diagnostic testing methods. Thus far, all therapies used for PCD are unproven through large clinical trials. This review article outlines consensus recommendations from PCD physicians in North America who have been engaged in a PCD centered research consortium for the last 10 years. These recommendations have been adopted by the governing board of the PCD Foundation to provide guidance for PCD clinical centers for diagnostic testing, monitoring, and appropriate short and long-term therapeutics in PCD patients.

KW - consensus statement

KW - PCD Foundation

KW - PCD, kartagener

KW - primary ciliary dyskinesia

UR - http://www.scopus.com/inward/record.url?scp=84955418865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955418865&partnerID=8YFLogxK

U2 - 10.1002/ppul.23304

DO - 10.1002/ppul.23304

M3 - Article

VL - 51

SP - 115

EP - 132

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

SN - 8755-6863

IS - 2

ER -